• the fda is a mess, but that doesn't mean it should be blamed for everything statnews.com Thu, 06 Nov 2025 11:34:05 GMT
• fda issues complete response letter to biohaven pharmaceuticals declining approval of spinocerebellar ataxia therapy geneonline.com Thu, 06 Nov 2025 08:05:15 GMT
• biohaven pharmaceuticals to cut r&d spending by 60% after fda rejection of vyglxia for spinocerebellar ataxia geneonline.com Thu, 06 Nov 2025 07:29:55 GMT
• biohaven sinks as fda declines to approve lead drug; bofa downgrades Seeking Alpha Wed, 05 Nov 2025 17:34:00 GMT
• fda rejects biohaven's ataxia drug, shutting down company's second attempt to win approval Endpoints News Wed, 05 Nov 2025 16:39:00 GMT
• biohaven shares plunge after us fda declines to approve brain disorder drug Reuters Wed, 05 Nov 2025 15:02:29 GMT
• fda issues complete response letter for spinocerebellar ataxia agent troriluzole Neurology Live Wed, 05 Nov 2025 14:44:26 GMT
• biohaven cuts r&d spending by 60% after fda rejection of drug for rare neurodegenerative disease BioSpace Wed, 05 Nov 2025 14:00:09 GMT
• dismay as fda declines to approve biohaven's ataxia drug pharmaphorum Wed, 05 Nov 2025 12:11:46 GMT
• FDA rejects Biohaven approval request for troriluzole, triggering R&D cost cutting Fierce Biotech Wed, 05 Nov 2025 08:00:00 GMT
• The Shocking Plot Twist That Sent This Biotech Crashing Investor's Business Daily Wed, 05 Nov 2025 08:00:00 GMT
• Knocked back by the FDA, Biohaven turns to major cost cuts BioPharma Dive Wed, 05 Nov 2025 08:00:00 GMT
• Biohaven sinks as FDA rejects lead drug (update) (BHVN:NYSE) Seeking Alpha Wed, 05 Nov 2025 08:00:00 GMT
• biohaven pharmaceutical stock hits 52-week low at $8.38 by investing.com Investing.com UK Wed, 05 Nov 2025 08:00:00 GMT
• fda issues complete response letter for biohaven's vyglxia (troriluzole) new drug application for spinocerebellar ataxia PR Newswire Wed, 05 Nov 2025 01:06:00 GMT
• biohaven pharmaceutical holding company ltd. (bhvn) analyst insights, price targets and recommendations Yahoo Finance UK Tue, 04 Nov 2025 23:47:28 GMT
• FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia PR Newswire Tue, 04 Nov 2025 08:00:00 GMT
• spinocerebellar ataxias clinical landscape, companies, therapeutic evaluation, therapies, treatment framework, and pipeline analys... Barchart.com Tue, 28 Oct 2025 07:00:00 GMT
• The limits of FDA flexibility are tested as a controversial Biohaven drug decision nears statnews.com Thu, 09 Oct 2025 07:00:00 GMT
• FDA to Decide on Biohaven’s Troriluzole for Rare Neurodegenerative Disease Amid Efficacy Concerns geneonline.com Thu, 09 Oct 2025 07:00:00 GMT
• should biohaven's (bhvn) accelerating cash burn and shorter runway require action from investors? Sahm Wed, 08 Oct 2025 07:00:00 GMT
• a look at biohaven (bhvn) valuation as cash runway narrows and funding concerns grow simplywall.st Mon, 06 Oct 2025 07:00:00 GMT
• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Mon, 29 Sep 2025 07:00:00 GMT
• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Fri, 26 Sep 2025 14:52:00 GMT
• Biohaven stock price target lowered to $26 at UBS on troriluzole timeline Investing.com UK Tue, 16 Sep 2025 07:00:00 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Mon, 08 Sep 2025 03:09:23 GMT
• biohaven pharmaceuticals prepares for vyglxia distribution pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 19:59:47 GMT
• biohaven pharmaceuticals announces immediate distribution of fda-approved spinocerebellar ataxia drug vyglxia geneonline.com Sun, 07 Sep 2025 14:14:30 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 01:07:35 GMT
• biohaven pharmaceuticals announces fda approval and immediate distribution of vyglxia for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 15:08:53 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 12:02:27 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval geneonline.com Sat, 06 Sep 2025 07:00:00 GMT
• Biohaven’s rare disease drug is ‘ready to ship on Day 1’ following FDA approval BioPharma Dive Wed, 03 Sep 2025 07:00:00 GMT
• price momentum metrics for biohaven ltd. explained - quarterly trade report & proven capital preservation methods Newser Thu, 28 Aug 2025 15:26:19 GMT
• brief—fda drops need for adcom on biohaven’s troriluzole The Pharma Letter Tue, 26 Aug 2025 07:00:00 GMT
• spinocerebellar ataxias clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline | biohaven ph... Barchart.com Tue, 26 Aug 2025 07:00:00 GMT
• focal epilepsy market: epidemiology, pipeline, companies, delveinsight | biocodex, biohaven therapeutics ltd., xenon pharmaceutica... Barchart.com Tue, 26 Aug 2025 00:34:18 GMT
• Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025 (NYSE:BHVN) Seeking Alpha Mon, 25 Aug 2025 07:00:00 GMT
• focal epilepsy market: epidemiology, pipeline, companies, delveinsight | biocodex, biohaven therapeutics ltd., xenon pharmaceutica... Barchart.com Mon, 25 Aug 2025 07:00:00 GMT
• what to do if you’re stuck in biohaven ltd. - weekly market outlook & precise swing trade alerts Newser Sat, 23 Aug 2025 19:54:16 GMT
• Biohaven rises as FDA cancels AdCom on lead drug (BHVN:NYSE) Seeking Alpha Fri, 22 Aug 2025 07:00:00 GMT
• FDA cancels adcomm on Biohaven drug; Catalent lays off staff Yahoo Finance Fri, 22 Aug 2025 07:00:00 GMT
• Biohaven gets a bump after FDA nixes adcom for troriluzole FirstWord Pharma Fri, 22 Aug 2025 07:00:00 GMT
• Biohaven says it won’t have to face FDA adcomm for its SCA drug Endpoints News Fri, 22 Aug 2025 07:00:00 GMT
• biohaven says fda will not hold advisory meeting for troriluzole application Investing.com Fri, 22 Aug 2025 07:00:00 GMT
• biohaven shares jump as fda cancels advisory meeting for rare disease drug Investing.com Fri, 22 Aug 2025 07:00:00 GMT
• motor neuron disease clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | bioha... Barchart.com Thu, 21 Aug 2025 07:00:00 GMT
• motor neuron disease clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | bioha... Barchart.com Wed, 20 Aug 2025 14:01:00 GMT
• jazz pharma broadens its prospects in epilepsy with deal for selective saniona drug MedCity News Wed, 20 Aug 2025 07:00:00 GMT
• chart based analysis of biohaven ltd. trends - bear alert & daily entry point trade alerts Newser Sun, 17 Aug 2025 02:23:39 GMT
• Biohaven files prospectus for resale of 3.6 million shares tied to Knopp deal Investing.com Fri, 15 Aug 2025 07:00:00 GMT
• biohaven's share resale and knopp amendment: implications for liquidity and governance risk AInvest Fri, 15 Aug 2025 07:00:00 GMT
• how legal challenges over drug pipeline disclosures at biohaven (bhvn) have changed its investment story simplywall.st Thu, 14 Aug 2025 07:00:00 GMT
• Biohaven trashes troriluzole in OCD after asset bungles phase 3 trial Fierce Biotech Tue, 12 Aug 2025 07:00:00 GMT
• biohaven scraps phase 3 ocd program; fosun’s licensing deal with expedition Endpoints News Tue, 12 Aug 2025 07:00:00 GMT
• biohaven pharmaceutical stock price target lowered to $30 at h.c. wainwright Investing.com UK Tue, 12 Aug 2025 07:00:00 GMT
• biohaven ltd. shares fall 1.79% premarket after reporting q2 earnings. AInvest Tue, 12 Aug 2025 07:00:00 GMT
• dilated cardiomyopathy clinical trials, companies, therapeutic assessment, emerging therapies, treatment algorithm, and pipeline a... Barchart.com Mon, 11 Aug 2025 21:34:31 GMT
• biohaven reports second quarter 2025 financial results and recent business developments PR Newswire Mon, 11 Aug 2025 07:00:00 GMT
• biohaven pharmaceuticals plunges 1.69% as class-action lawsuit alleges misleading drug claims AInvest Wed, 30 Jul 2025 07:00:00 GMT
• obsessive compulsive disorder clinical trials 2025: ema, pdma, fda approvals, medication, pipeline, therapies, mechanism of action... The Globe and Mail Tue, 22 Jul 2025 10:47:14 GMT
• biohaven’s volatility: a sudden surge amid regulatory turmoil AInvest Thu, 17 Jul 2025 07:00:00 GMT
• biohaven's regulatory labyrinth: can the stock survive the delays and litigation? AInvest Thu, 17 Jul 2025 01:26:06 GMT
• biohaven, bexorg partner to accelerate cns drug discovery using novel whole-brain platform MSN Wed, 16 Jul 2025 13:58:39 GMT
• biohaven's regulatory labyrinth: can the stock survive the delays and litigation? AInvest Wed, 16 Jul 2025 07:00:00 GMT
• Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform Yahoo Finance Tue, 15 Jul 2025 07:00:00 GMT
• biohaven and bexorg: pioneering a new era in cns drug development AInvest Tue, 15 Jul 2025 07:00:00 GMT
• biohaven pharmaceutical stock hits 52-week low at 13.68 usd by investing.com Investing.com UK Tue, 15 Jul 2025 07:00:00 GMT
• spinocerebellar ataxias pipeline 2025: moa, roa, and clinical trial insights explored by delveinsight | biogen inc, bioxcel corp, ... Barchart.com Mon, 14 Jul 2025 14:06:05 GMT
• motor neuron disease clinical trials, companies, therapeutic openPR.com Fri, 11 Jul 2025 07:00:00 GMT
• biohaven (bhvn) fda approvals, pdufa dates & drug alerts 2025 MarketBeat Wed, 09 Jul 2025 14:23:07 GMT
• novel glp-1/gip agent led to weight loss with once-monthly dosing MedPage Today Mon, 23 Jun 2025 07:00:00 GMT
• spinocerebellar ataxia: pipeline drugs and emerging therapies openPR.com Tue, 17 Jun 2025 07:00:00 GMT
• bexorg announces research collaboration with biohaven leveraging its novel ai-driven whole-brain discovery platform to enhance cns... Yahoo Finance Tue, 10 Jun 2025 07:00:00 GMT
• biohaven and bexorg: pioneering a new frontier in neurodegenerative drug development AInvest Tue, 10 Jun 2025 07:00:00 GMT
• bexorg-biohaven: a paradigm shift in cns drug discovery through ai-driven synergy AInvest Tue, 10 Jun 2025 07:00:00 GMT
• spinal muscular atrophy pipeline drugs analysis 2025: clinical trials, ema, pdma, fda approvals, medication, treatment market, nda... The Globe and Mail Mon, 09 Jun 2025 07:00:00 GMT
• abcuro hires ex-alexion, biohaven exec to lead commercial team ahead of planned launch Fierce Pharma Mon, 09 Jun 2025 07:00:00 GMT
• biohaven ltd. highlights strategic focus in investor presentation TipRanks Wed, 04 Jun 2025 07:00:00 GMT
• Breakthrough Parkinson's Treatment: Biohaven's Novel Brain Drug Enters Pivotal Trial for 10M Patients Stock Titan Thu, 29 May 2025 07:00:00 GMT
• biohaven enrolls first patient into phase 2/3 trial in early parkinson's disease, targeting neuroinflammation with novel brain-pen... PR Newswire Thu, 29 May 2025 07:00:00 GMT
• td cowen on biohaven pharmaceutical holding (bhvn): 'this pipeline is impressive', 'buy bhvn' StreetInsider Thu, 29 May 2025 07:00:00 GMT
• biohaven says anti-cancer agent cut tumor size (bhvn:nyse) Seeking Alpha Wed, 28 May 2025 18:44:00 GMT
• biohaven pharma (bhvn) presents oncology program updates and preliminary clinical data showcasing innovative trop2 and fgfr3 antib... StreetInsider Wed, 28 May 2025 11:33:12 GMT
• Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conju... PR Newswire Wed, 28 May 2025 07:00:00 GMT
• breakthrough: biohaven's new cancer drug achieves perfect response rate in first 6 patients treated Stock Titan Wed, 28 May 2025 07:00:00 GMT
• biohaven pharma (bhvn) highlights innovation and advancement across mode and trap degrader platform at r&d day StreetInsider Wed, 28 May 2025 07:00:00 GMT
• biohaven says anti-cancer agent cut tumor size with regeneron’s libtayo in phase 1 trial Seeking Alpha Wed, 28 May 2025 07:00:00 GMT
• breakthrough iga nephropathy treatment achieves 81% disease marker reduction in first-in-class trial Stock Titan Wed, 28 May 2025 07:00:00 GMT
• biohaven highlights innovation and advancement across mode and trap degrader platform at r&d day, announcing positive trap degrade... PR Newswire Wed, 28 May 2025 07:00:00 GMT
• inozyme pharma and biohaven pharmaceuticals announce leadership changes amid industry restructuring geneonline.com Mon, 26 May 2025 07:00:00 GMT
• biotech tumbles on a surprise fda twist for its rare-disease drug Investor's Business Daily Thu, 15 May 2025 20:22:00 GMT
• Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug Investor's Business Daily Thu, 15 May 2025 07:00:00 GMT
• FDA delays approval decision for Biohaven rare disease drug BioPharma Dive Thu, 15 May 2025 07:00:00 GMT
• FDA delays decision on Biohaven's rare disease drug filing, plans adcomm Fierce Biotech Thu, 15 May 2025 07:00:00 GMT
• Biohaven stock slides as FDA delays drug review (BHVN:NYSE) Seeking Alpha Thu, 15 May 2025 07:00:00 GMT
• fda delays decision date on biohaven’s spinocerebellar ataxia application BioSpace Thu, 15 May 2025 07:00:00 GMT
• fda extends pdufa date of biohaven's troriluzole nda for rare disease spinocerebellar ataxia PR Newswire Wed, 14 May 2025 07:00:00 GMT
• Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments PR Newswire Mon, 12 May 2025 07:00:00 GMT
• trigeminal neuralgia market predicted to see upsurge through 2032, highlights delveinsight | noema pharma ag, biohaven pharmaceuti... Barchart.com Fri, 09 May 2025 14:44:00 GMT
• facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously BioPharma Dive Tue, 06 May 2025 16:23:16 GMT
• Biohaven secures $600m financing as it awaits FDA prodrug decision Pharmaceutical Technology Tue, 29 Apr 2025 07:00:00 GMT
• biohaven grabs a foothold with $600m windfall from oberland capital BioSpace Tue, 29 Apr 2025 07:00:00 GMT
• Biohaven Announces Investment up to $600 Million by Oberland Capital PR Newswire Mon, 28 Apr 2025 07:00:00 GMT
• Biohaven, after setbacks, sees shares jump with Oberland Capital funding agreement worth up to $600M Fierce Biotech Mon, 28 Apr 2025 07:00:00 GMT
• Biohaven secures $600M financing ahead of FDA verdict on ataxia drug FirstWord Pharma Mon, 28 Apr 2025 07:00:00 GMT
• biohaven pharma (bhvn) announces investment up to $600 million by oberland capital StreetInsider Mon, 28 Apr 2025 07:00:00 GMT
• biohaven lands massive $600m backing to advance first-ever treatment for rare genetic disease Stock Titan Mon, 28 Apr 2025 07:00:00 GMT
• biohaven's pipeline potential outshines near-term setbacks, says rbc capital AInvest Sat, 26 Apr 2025 07:00:00 GMT
• biohaven pharma stock tumbles after withdrawal of dazluma application in eu Investing.com Australia Sat, 26 Apr 2025 07:00:00 GMT
• biohaven drops after pulling eu marketing application for rare disorder drug MSN Fri, 25 Apr 2025 16:51:50 GMT
• Biohaven stock slides on withdrawal of European marketing application BioPharma Dive Fri, 25 Apr 2025 07:00:00 GMT
• biohaven pharma stock tumbles after withdrawal of dazluma application in eu Investing.com Nigeria Fri, 25 Apr 2025 07:00:00 GMT
• biohaven pharmaceutical : announces pricing of $250 million public offering of common shares marketscreener.com Sat, 19 Apr 2025 14:48:46 GMT
• biohaven’s bhv-8000 rescues locomotor deficits in parkinson’s disease BioWorld MedTech Thu, 17 Apr 2025 07:00:00 GMT
• biohaven’s bhv-1310 shows promise for autoimmune disorders BioWorld MedTech Wed, 16 Apr 2025 07:00:00 GMT
• biohaven pharmaceutical : enrolls first patient in phase 2 clinical trial of rimegepant, oral cgrp receptor antagonist, for treatm... marketscreener.com Mon, 14 Apr 2025 12:00:04 GMT
• why biotech stocks such as biohaven, recursion pharmaceuticals, and crispr therapeutics plunged in march MSN Wed, 09 Apr 2025 10:57:13 GMT
• royalty pharma expands board with biohaven ceo appointment by investing.com Investing.com India Wed, 09 Apr 2025 07:00:00 GMT
• royalty pharma expands board with biohaven ceo appointment Investing.com Tue, 08 Apr 2025 07:00:00 GMT
• biotech leader behind $13b pfizer-biohaven deal takes strategic role at royalty pharma Stock Titan Tue, 08 Apr 2025 07:00:00 GMT
• novel bispecific degrader bhv-1310 eliminates intravascular and interstitial igg within multiple organs and anatomical structures ... Neurology® Journals Mon, 07 Apr 2025 07:00:00 GMT
• why biotech stocks such as biohaven, recursion pharmaceuticals, and crispr therapeutics plunged in march Nasdaq Thu, 03 Apr 2025 07:00:00 GMT
• pfizer's $11.6 billion biohaven buy could spark more biotech deals MarketScreener Mon, 31 Mar 2025 15:45:45 GMT
• multiple system atrophy market to reach new heights in growth by 2034, delveinsight predicts | ionis pharma, biohaven pharma, lund... Barchart Thu, 20 Mar 2025 13:03:01 GMT
• biohaven's verdiperstat receives fast track designation for the treatment of multiple system atrophy Reuters Tue, 18 Mar 2025 07:00:00 GMT
• morgan stanley cuts biohaven stock price target to $63 from $69 Investing.com Thu, 06 Mar 2025 08:00:00 GMT
• biohaven pharmaceutical holding (bhvn) pt lowered to $63 at jefferies StreetInsider Wed, 05 Mar 2025 08:00:00 GMT
• Biohaven’s pivotal bipolar drug trial fails, stock takes hit Clinical Trials Arena Tue, 04 Mar 2025 08:00:00 GMT
Biohaven Pharmaceuticals(NYSE:BHVN) 
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive t...
Website: http://www.biohavenpharma.com
Founded: 2013
Full Time Employees: 647
CEO: Vlad Coric
Sector: Healthcare
Industry: Biotechnology